MXPA04005366A - Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros. - Google Patents

Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros.

Info

Publication number
MXPA04005366A
MXPA04005366A MXPA04005366A MXPA04005366A MXPA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A MX PA04005366 A MXPA04005366 A MX PA04005366A
Authority
MX
Mexico
Prior art keywords
alpha
amino acids
chirally pure
salt
sulfonyl
Prior art date
Application number
MXPA04005366A
Other languages
English (en)
Spanish (es)
Inventor
Resnick Lynn
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46204648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04005366(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US10/014,304 external-priority patent/US6610734B2/en
Priority claimed from US10/166,896 external-priority patent/US6657070B2/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA04005366A publication Critical patent/MXPA04005366A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA04005366A 2001-12-11 2002-11-26 Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros. MXPA04005366A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/014,304 US6610734B2 (en) 2000-12-13 2001-12-11 Heterocyclic sulfonamide inhibitors of beta amyloid production
US10/166,896 US6657070B2 (en) 2000-12-13 2002-06-11 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
PCT/US2002/038117 WO2003050062A2 (en) 2001-12-11 2002-11-26 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS

Publications (1)

Publication Number Publication Date
MXPA04005366A true MXPA04005366A (es) 2004-09-27

Family

ID=46204648

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005366A MXPA04005366A (es) 2001-12-11 2002-11-26 Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros.

Country Status (7)

Country Link
EP (1) EP1461332A4 (https=)
JP (1) JP4615861B2 (https=)
AU (2) AU2002351170B8 (https=)
CA (1) CA2470111A1 (https=)
MX (1) MXPA04005366A (https=)
TW (1) TWI260316B (https=)
WO (1) WO2003050062A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0303857A3 (en) 2000-12-13 2007-07-30 Wyeth Corp Heterocyclic sulifonamide inhibitors of beta amyloid production
BRPI0408962A (pt) 2003-03-31 2006-04-04 Wyeth Corp inibidores sulfonamidas heterocìclicos contendo flúor- e trifluoroalquila da produção de beta amilóide e seus derivados
ES2330451T3 (es) 2004-01-16 2009-12-10 Wyeth Inhibidores a base de sulfonamidas heterociclicas de la produccion de beta-amiloides que contienen un azol.
JP2009534385A (ja) 2006-04-21 2009-09-24 ワイス キラル的に純粋なアミノアルコール中間体、それらの誘導体の製造、及びそれらの使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3802981A1 (de) * 1988-02-02 1989-08-10 Basf Ag Verfahren zur reduktion reduzierbarer verbindungen
US5264577A (en) * 1992-04-22 1993-11-23 Warner-Lambert Company Cyclic amino acids and derivatives thereof
ATE218541T1 (de) * 1992-08-25 2002-06-15 Searle & Co Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US6191306B1 (en) * 1999-08-03 2001-02-20 Eastman Chemical Company Process for the preparation of cyclopropylglycine

Also Published As

Publication number Publication date
WO2003050062A3 (en) 2003-11-20
AU2002351170B2 (en) 2009-09-24
WO2003050062A2 (en) 2003-06-19
JP2005511727A (ja) 2005-04-28
EP1461332A2 (en) 2004-09-29
TWI260316B (en) 2006-08-21
AU2009251195A1 (en) 2010-01-21
EP1461332A4 (en) 2009-10-21
CA2470111A1 (en) 2003-06-19
AU2002351170A1 (en) 2003-06-23
TW200306292A (en) 2003-11-16
AU2002351170B8 (en) 2009-10-08
JP4615861B2 (ja) 2011-01-19

Similar Documents

Publication Publication Date Title
US8217197B2 (en) Process for producing methionine
US8680329B2 (en) Process for preparation of α-ketoglutaric acid
CN101735126A (zh) 用于制备甲硫氨酸的方法
CN101830818B (zh) 一种无水甜菜碱的制备方法
CN101973941A (zh) 一种制备对羟基苯海因的方法
CN104592064A (zh) 一种2-氨基苯酚-4-磺酰胺的合成方法
GB2437006A (en) Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture
CN110252395B (zh) 一种用于制备高纯度牛磺酸的催化剂及其应用
MXPA04005366A (es) Produccion de alfa-aminoacidos de n-sulfonilo y alfa-aminoacidos quiralmente puros.
CN101723773B (zh) 高纯度n-乙酰-dl-氨基酸的制备方法
CN102276423A (zh) 对苯二胺直接水解法生产对苯二酚的方法
CN106905262A (zh) 一种制备高纯度4‑羟乙基哌嗪乙磺酸的方法
CN102126970B (zh) 选择性沉淀分离亮氨酸、精氨酸的方法
CN108558688A (zh) 一种利用β-氨基丙腈制备β-氨基丙酸的方法
CN101445530B (zh) 一种橙皮苷的高生物利用率衍生物的制备方法
CN106008392B (zh) 一种抗癌药物达沙替尼的中间体的制备方法
CN102399191B (zh) 一种安乃近的合成方法
CN102329286B (zh) 一种新的合成3-氧杂环丁酮的方法
CN103242186B (zh) 一种甲基丙烯酰胺和甲基丙烯酸甲酯的联合生产方法
WO2019218445A1 (zh) 一种脲酶抑制剂乙酰氧肟酸的合成方法
CN106083734A (zh) 一种制备2‑氯嘧啶‑4甲酸的方法
JP2011519840A (ja) １，７’−ジメチル−２’−プロピル−２，５’−ビ−１ｈ−ベンゾイミダゾールの製造
CN104178534A (zh) 一种以南极磷虾为原料制备l-酪氨酸的方法
CN103145578B (zh) 一种甲基丙烯酰胺的制备和提纯方法
CN103981248A (zh) 一种拆分外消旋亮氨酸的方法

Legal Events

Date Code Title Description
FG Grant or registration